Pfizer Readies Bid for Ratiopharm: Report
Pfizer is expected Wednesday to place an offer in the final round of bids for German generic drugmaker Ratiopharm, a report says.
NEW YORK (
) --
Pfizer
(PFE) - Get Report
is expected Wednesday to place an offer in the final round of bids for German generic drug maker
Ratiopharm
, a report says.
Pfizer officials weren't available to comment for the report from
Reuters
.
Other bidders include Israel's
Teva
(TEVA) - Get Report
and Iceland's
Actavis
which had been requested to make final bids on Thursday at the latest, several sources told
Reuters
.
So far, Actavis' bid has been the highest at about 3 billion euros ($4.13 billion), including assumed debt.
Debt-laden Actavis has raised the prospect of taking the enlarged company public should it win the auction, people familiar with the sale process told
Reuters
.
Follow TheStreet.com on
and become a fan on
